In preclinical drug development, in vivo studies are a mandatory step in the process of turning lead compounds into drug candidates. Regulatory agencies require in vivo safety and efficacy data from animal models before approving novel candidates..
Drug discovery and development lead to new treatments for diseases. However, it is a costly, time-consuming and challenging process—developing a marketable drug can take more than 10 years and cost around a billion dollars. One of the reasons for..
In recent years, the reproducibility of scientific research has come under the spotlight. A major barrier to clinical development is the inability of translational scientists to replicate early discovery findings. In 2016, Nature surveyed nearly..
Data integrity is not a new problem and continues to be the major focus in regulated cGMP laboratories worldwide due to data falsification, poor data management practices, or ignorance of the regulations. Several regulatory agencies such as the..
When the human genome was sequenced in 2003, it became possible to identify the gene and protein changes that occur in various diseases, such as cancer. Ever since, the field of proteomics has been booming to respond to the ever-increasing..
Research scientists spend 50-80% of their time at the bench with no easy way to record data or access information. New voice-powered digital tools solve this problem by connecting scientists with information at the point of experimentation.